The original patent's negotiation period will be reduced
By Kim, Jung-Ju | translator Choi HeeYoung
21.11.25 18:27:05
°¡³ª´Ù¶ó
0
The MOHW reports to the Health Policy Deliberation Committee
Detailed procedures regulations after the spread of the negotiation system
The period of ex officio adjustment drug price negotiations for the original drug that expires patents collectively cut drug prices will be reduced to one-third. It is aimed at improving cases of health insurance financial leaks by abusing the prescribed negotiation period as much as possible when the legal drug price cut rate is set.
The MOHW announced that it held a Health Insurance Policy Deliberation Committee this afternoon (25th) and reported on the "improvement of the drug negotiation system." The government is currently negotiating all reimbursed drugs. This is in accordance with the policy to expand the negotiated drugs from the application of new drug insurance to the entire drug from October 202
Kim, Jung-Ju(jj0831@dailypharm.com)
If you want to see the full article, please JOIN US (click)